Skip to content

CU HEALTHCARE INNOVATION MANAGEMENT, LLC

CU HEALTHCARE INNOVATION MANAGEMENT, LLC is a Seed, Series A, Series B and Series C+ fund in the US writing $1M–$50M checks into Healthcare, tech-enabled-services, medical-devices, diagnostics and therapeutics.

Stages
Seed, Series A, Series B, Series C+
Sectors
Healthcare, tech-enabled-services, medical-devices, diagnostics, therapeutics
Check size
$1M–$50M
Invests in
US-wide
Actively investing
Yes
Founded
2019
Assets under management
$100M

Thesis

The CU Healthcare Innovation Fund, founded in 2019 and affiliated with the University of Colorado Anschutz Medical Campus (CU Anschutz), is a strategic venture capital firm with $100 million in AUM. It focuses on early-stage healthcare companies, particularly those with a connection or potential partnership with CU Anschutz institutions, aiming to foster innovation in digital health, tech-enabled services, medical devices, diagnostics, and therapeutics. The fund actively seeks companies addressing unmet medical needs with strong IP and clear commercialization paths, investing across Seed to Late Stage, with a focus on Series A and B rounds. Investments typically range from $1 million to $50 million. The geographic scope is primarily the United States, with an emphasis on companies that can collaborate with CU Anschutz for de-risking and validation, creating a 'living laboratory' for clinical trials and co-development.

Common questions

Does CU HEALTHCARE INNOVATION MANAGEMENT, LLC invest at the Seed stage?

Yes. CU HEALTHCARE INNOVATION MANAGEMENT, LLC lists Seed, Series A, Series B and Series C+ among the stages it invests in.

What check size does CU HEALTHCARE INNOVATION MANAGEMENT, LLC write?

CU HEALTHCARE INNOVATION MANAGEMENT, LLC writes $1M–$50M checks.

Where does CU HEALTHCARE INNOVATION MANAGEMENT, LLC invest?

CU HEALTHCARE INNOVATION MANAGEMENT, LLC invests in the US.

Related lists